Smead Value I1 (SVFFX)

Nasdaq • Currently up 0.69 (+0.67%) in today's trading session

1 member of Congress has disclosed 4 trades in Smead Value I1 (SVFFX) via STOCK Act filings. The most recent disclosure was a purchase by Chris Pappas on 18 August 2025. Aggregate disclosed activity totals roughly $32K in purchases (midpoint estimates from bracketed disclosure amounts).

Smead Value I1 is currently trading at $103.56, positioned at 100% of its 52-week range ($78.85 – $103.64).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$103.56
24h Change
+0.69 (+0.67%)
52 Week Range
$78.85—$103.64
View on NASDAQ

Smead Value I1 Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for SVFFX

Select to highlight on chart
0 transactions
Compliance: 0%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$4.15B

Volume

0

Beta

0.72

P/E Ratio

18.83

Fundamentals

EPS

$5.50

Div. Yield

1.56%

Open

$103.56

Day Range

$103.56 — $103.56

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
NASDAQ · USD
Country
US
IPO Date
2009-12-21
Website
smeadcap.com/smead-value-fund

In pursuit of its financial objectives, the fund strategically builds a focused portfolio generally comprising 25 to 30 companies. Its investments are concentrated in the equity securities of substantial U.S. enterprises, known as "large-cap" firms....

No earnings data available for this stock.

Dividends

Dividend History

18 Dec 2025
Amount $1.6204
12 Dec 2024
Amount $1.1149
14 Dec 2023
Amount $1.2434
15 Dec 2022
Amount $1.3658
16 Dec 2021
Amount $2.8916
17 Dec 2020
Amount $0.8510
19 Dec 2019
Amount $2.0670
13 Dec 2018
Amount $3.1060
14 Dec 2017
Amount $2.2800
15 Dec 2016
Amount $1.3850
17 Dec 2015
Amount $1.3310
16 Dec 2014
Amount $1.8950
19 Dec 2013
Amount $1.2280
19 Dec 2012
Amount $0.4710
28 Dec 2011
Amount $0.1760
28 Dec 2010
Amount $0.0930

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about SVFFX

Which members of Congress have traded SVFFX?
1 member of Congress has disclosed 4 trade in Smead Value I1 (SVFFX) under the STOCK Act: Chris Pappas.
When was SVFFX most recently disclosed by Congress?
The most recent SVFFX disclosure was a purchase by Chris Pappas on 18 August 2025.
What is the total disclosed congressional trading volume for SVFFX?
Members of Congress have disclosed approximately $32K in SVFFX purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in SVFFX?
This SVFFX page updates as soon as new STOCK Act disclosures are filed for Smead Value I1. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.